Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Pressure BioSciences Inc. (PBIO : OTC)

• Company Description    Pressure BioSciences, Inc is a company focused on the development of a novel technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (35,000 psi and greater) to control bio- molecular interactions. Pressure BioSciences holds US and foreign patents covering multiple applications of PCT in the life sciences field, including in such areas as genomic and proteomic sample preparation, pathogen inactivation, control of enzymes, immunodiagnostics, and protein purification. Number of Employees: 12

• Price / Volume Information    Yesterday's Closing Price: $1.70 Daily Weekly Monthly 20 Day Moving Average: 17,813 shares Shares Outstanding: 8.79 (millions) Market Capitalization: $14.94 (millions) Beta: 0.70 52 Week High: $4.98 52 Week Low: $1.58 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -4.49% 4.23% 12 Week -19.05% -14.77% Year To Date -26.41% -14.22%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 14 NORFOLK AVENUE - SOUTH EASTON,MA 02375 USA ph: 508-230-1828 fax: 508-230-1829 ir@pressurebiosciences.com http://www.pressurebiosciences.com

• General Corporate Information    Officers Richard T. Schumacher - Chief Executive Officer; President; CFO and Direct Jeffrey N. Peterson - Chairman Mickey Urdea - Director Vito J. Mangiardi - Director Kevin A. Pollack - Director Peer Information Pressure BioSciences Inc. (ABMD) Pressure BioSciences Inc. (DMDS) Pressure BioSciences Inc. (CPWY.) Pressure BioSciences Inc. (EQUR) Pressure BioSciences Inc. (ECIA) Pressure BioSciences Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 74112E208 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/21 Next Expected EPS Date: 05/18/22 Share - Related Items Shares Outstanding: 8.79 Most Recent Split Date: 6.00 (0.03:1) Beta: 0.70 Market Capitalization: $14.94 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/18/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 7.46 EPS Growth vs. Year Ago Period: 63.64% vs. Previous Quarter: 51.22% Sales Growth vs. Year Ago Period: 90.91% vs. Previous Quarter: -39.19% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - - 12/31/21 - -735.75 09/30/21 - -785.50 Current Ratio 03/31/22 - - 12/31/21 - 0.08 09/30/21 - 0.12 Quick Ratio 03/31/22 - - 12/31/21 - 0.03 09/30/21 - 0.08 Operating Margin 03/31/22 - - 12/31/21 - -1,006.69 09/30/21 - -1,105.72 Net Margin 03/31/22 - - 12/31/21 - -1,006.69 09/30/21 - -1,105.72 Pre-Tax Margin 03/31/22 - - 12/31/21 - -1,006.64 09/30/21 - -1,105.72 Book Value 03/31/22 - - 12/31/21 - -2.63 09/30/21 - -2.74 Inventory Turnover 03/31/22 - - 12/31/21 - 1.26 09/30/21 - 1.31 Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©